Viking Therapeutics accuses competitor of pilfering proprietary information By / On January 12, 2023 / At 11:30 pm / In Chemical world 27 Views The lawsuit concerns a small molecule that treats metabolic diseases Post navigation Prev PostFDA green-lights lecanemab to treat Alzheimer’s disease Next PostBraskem buys taulman3D You May Also Like Editing the structure of molecules On March 27, 2023 | In Chemical world Regenerative engineering: Polymeric chemistry and materials science for regeneration On March 26, 2023 | In Chemical world Periodic Graphics: Making molecular sandwiches On March 26, 2023 | In Chemical world